Brainsway (BRSYF) Restructuring Costs (2023)
Brainsway's (BRSYF) quarterly Restructuring Costs came in at $267000.0 in Q2 2023.
Powered by 
Analysis
Brainsway (BRSYF) Restructuring Costs (2023) Analysis & Trends
Brainsway (BRSYF) has reported Restructuring Costs for 1 consecutive years, with $267000.0 the latest figure, recorded in Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn |
| 10 | Brainsway | 592.58 Mn | 529.41 Mn | 12.77 Mn |